Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Bounces Back In Q3, Led By Interventional Devices

Oct 14 2020

• By Reed Miller

JNJ — • Source: shutterstock.com

Related Content

J&J Says It's Wait And See On COVID-19 Vaccine Delay, Outlines Rosier Outlook for 2021

Oct 13 2020

J&J, Acutus And Boston Scientific Announce Plans For Pulsed Field AF-Ablation Technologies

Oct 05 2020

Role Of Digital Surgery Will Continue To Grow Despite Cost Constraints

Oct 08 2020

COVID-19 Medtech Lessons: Data Point To ‘Healthy Industry In An Unhealthy Time’ But Business Models Must Change

Oct 13 2020

J&J Bullish On Procedure Recovery As Q2 Device Sales Beat Analyst Expectations

Jul 17 2020

Related Companies

Johnson & Johnson

Additional Topics

Coronavirus COVID-19 Companies Commercial Business Strategies Research & Development Cardiovascular Orthopedics Cardiology Robotic Surgery Surgery Wound Management Medical Device

More from Business

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window